Publications de 2015

1.  HandiVIH. Understanding the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations.  De Beaudrap P, Pasquier E, Noelle A, et al.  Open BMJ (en cours de révision, 2015)

2.  Incidence, trends and predictors of infectious morbidity after second line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon (submitted CID, 2015).

3.  Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa: the ANRS 12169/2LADY randomised trial. Ciaffi L1, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E;2LADY Study Group. AIDS 2015, Jul 31;29(12):1473–1481

4.  Vers une matrice de l’action publique en Afrique ? Approche trans-sectorielle de l’action publique en Afrique contemporaine. Eboko Fred  CERI Sciences Po, 2015, février 2015 : 1-40. (Questions de Recherche, n° 45)

5.  Gouvernance et sida en Afrique. Instruments de l’action publique internationale ; l’exemple du Fonds Mondial. Eboko Fred, Hane Fatoumata, Demange Elise, Faye Sylvain  Mondes en Développement, 2015, n° 70 : 59-74.

6.  Feasibility of Routinely Offering Early Combined Antiretroviral Therapy to HIV-infected Infants in a Resource-limited Country: The ANRS-PediaCAM Study in Cameroon. Tejiokem MC, Warszawski J, Ateba Ndongo F, Tetang Ndiang S, Ndongo JA, Owona F, Ngoupo PA, Tchendjou P, Kfutwah A, Penda IC, Faye A. Pediatr Infect Dis J. 2015 Oct;34(10):e248-53

7.  Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants? Ateba Ndongo F, Warszawski J, Texier G, Penda I, Tetang Ndiang S, Ndongo JA, Guemkam G, Sofeu CL, Kfutwah A, Faye A, Msellati P, Tejiokem MC; ANRS-PEDIACAM study group. BMC Pediatr. 2015 Sep 21;15(1):132. doi: 10.1186/s12887-015-0451-3.

8.  Different factors associated with loss to follow-up of infants born to HIV-infected or uninfected mothers: observations from the ANRS 12140-PEDIACAM study in Cameroon. Sidze LK, Faye A, Tetang SN, Penda I, Guemkam G, Ateba FN, Ndongo JA, Nguefack F, Texier G, Tchendjou P, Kfutwah A, Warszawski J, Tejiokem MC. BMC Public Health. 2015 Mar 7;15:228.

9.  Origin of the HIV-1 group O epidemic in western lowland gorillas. D’arc M, Ayouba A, Esteban A, Learn GH, Boué V, Liegeois F, Etienne L, Tagg N, Leendertz F, Boesch C, Madinda N, Robbins M, Gray M, Cournil A, Ooms M, Letko M, Simon V, Sharp P, Hahn B, Delaporte E, Mpoudi Ngole E, Peeters M. Proc. Natl. Acad. Sci. USA. 2015 ; 112: E1343-52

10.  High Rate of Simian Immunodeficiency Virus (SIV) Infections in wild Living Chimpanzees in Northeastern Gabon. Boué V, Locatelli S, Boucher F, Butel C, Esteban A, Okouga A, Ndoungouet A, Motsch P, Le Flohic G, Ngari P, Prugnolle P, Ollomo B, Rouet  F, Liégeois F. Viruses. 2015 Sep 15;7(9):4997-5015.

11.  HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges. Villabona-Arenas CJ, Domyeum J, Mouacha F, Butel C, Delaporte E, Peeters M, Mpoudi-Ngole E, Aghokeng AF. Infect Genet Evol. 2015; 36:210-216.

12.  Molecular characterization of a new mosaic Simian Immunodeficiency Virus in a naturally infected tantalus monkey (Chlorocebus tantalus) from Cameroon: a challenge to the virus-host co-evolution of SIVagm in African green monkeys. Ayouba A, Njouom R, Chia JE, Ahuka-Mundeke S, Kfutwah A, Ngole EM, Nerrienet E, Delaporte E, Peeters M. Infect Genet Evol. 2015; 30:65-73.

13.  Stability of the gorilla microbiome despite simian immunodeficiency virus infection. Moeller A, Peeters M, Ayouba A, Mpoudi Ngole E, Esteban A, Hahn B, Ochman H. Mol. Ecol. 2015 ; 24:690-697

14.  First evidence of transmission of an HIV-1 M/O intergroup recombinant virus. Ngoupo PA, Sadeuh-Mba SA, De Oliveira F, Ngono V, Ngono L, Tchendjou P, Penlap Mbeng V, Mourez T, Njouom R, Kfutwah A , Plantier JC. AIDS. 2015 sous presse.

15.  Wild gorillas as a potential reservoir of Leishmania major. Hamad I, Forestier CL, Peeters M, Delaporte E, Raoult D, Bittar F. J Infect Dis. 2015; 211(2):267-73.

16.  The sampling scheme matters: Pan troglodytes troglodytes and P. t. schweinfurthii are characterized by clinal genetic variation rather than a strong subspecies break. Fünfstück T, Arandjelovic M, Morgan DB, Sanz C, Reed P, Olson SH, Cameron K, Ondzie A, Peeters M, Vigilant L. Am J Phys Anthropol. 2015 Feb;156(2):181-91.

17.  The population genetics of wild chimpanzees in Cameroon and Nigeria suggests a positive role for selection in the evolution of chimpanzee subspecies. Mitchell MW, Locatelli S, Ghobrial L, Pokempner AA, Sesink Clee PR, Abwe EE, Nicholas A, Nkembi L, Anthony NM, Morgan BJ, Fotso R, Peeters M, Hahn BH, Gonder MK. BMC Evol Biol. 2015; 15:3.

18.  Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon. Charlotte, Boullé, Kouanfack C, Laborde-Balen Gabrièle, Boyer Sylvie, Aghokeng Avelin F, Carrieri Maria P, Kazé Serge, Dontsop Marlise, Mben Jean-Marc, Koulla-Shiro Sinata, Peytavin Gilles, Spire Bruno, Delaporte Eric, Laurent Christian. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):355-64. doi: 10.1097/QAI.0000000000000604.

19.  Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy]. M, Suzan-Monti, Blanche J, Boyer S, Kouanfack C, Delaporte E, Bonono R-C, Carrieri Pm, Protopopescu C, Laurent C, Spire B. HIV Med. 2015 May;16(5):307-18. doi: 10.1111/hiv.12213.

20.  Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy. Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G; on behalf of the DAYANA Study Group. J Antimicrob Chemother. 2015 May;70(5):1517-21. doi: 10.1093/jac/dku532